Insufficient Genetic Data Forbode Trial Stoppages

A new study finds that clinical trials are more likely to stop early if there is no genetic evidence for the treatment. Insufficient patient enrollment is the main cause for early termination in trials overall. But the results show that cancer trials are more likely to end prematurely because of safety concerns.